Nogacka, A; Salazar, N; Arboleya, S; Suárez, M; Fernández, N; Solís, G; de los Reyes-Gavilán, CG and Gueimonde, M. Early microbiota, antibiotics and health. Cellular and Molecular Life Sciences. 2018. 75:83-91.
Ravi, A; Valdes-Varela, L; Borges, PJA; Gueimonde, M and Rudi, K. Transmission and persistence of IncF conjugative plasmids in the gut microbiota of full term infants. FEMS Microbial Ecology. 2018. 94:fix158
Ríos-Covián, D; Nogacka, A; Salazar, N; Hernández-Barranco, AM; Cuesta, I; Gueimonde, M and de los Reyes-Gavilán, CG. Bifidobacterium breve IPLA20005 affects “in vitro” the expression of hly and LuxS genes, related to the virulence of Listeria monocytogenes Lm23. Canadian Journal of Microbiology. 2018. 64:215-221.
Fernández-Navarro, T; Salazar, N; Gutiérrez-Díaz, I; Sánchez, B; Ruas-Madiedo, P; de los Reyes-Gavilán, CG; Margolles, A; Gueimonde, M and González, S. Bioactive compounds from regular diet and faecal microbial metabolites. European Journal of Nutrition. 2018. 57:487-497.
Valdés-Varela, L; Gueimonde, M and Ruas-Madiedo, P. Probiotics for prevention and treatment of Clostridium difficile infection. Advances in Experimental Medicine and Biology. 2018. 1050:161-76
Gil-Sánchez, I; Esteban-Fernández, A; González de Llano, D; Sanz-Buenhombre, M; Guadarrana, A; Salazar, N; Gueimonde, M; de los Reyes-Gavilán, CG; Martín Gómez, L; García Bermejo, ML; Bartolomé, B and Moreno-Arribas, MV. Supplementation with grape pomace in healthy women: changes in biochemical parameters, gut microbiota and related metabolic biomarkers. Journal of Functional Foods. 2018. 45:34-36.
Arboleya, S; Suárez, M; Fernández, N; Mantecón, L; Solís, G; Gueimonde, M and de los Reyes-Gavilán, CG. C-section and the neonatal gut microbiome acquisition: consequences for future health. Annals of Nutrition and Metabolism. 2018. 73(suppl.3):17-23.
Nogacka, A; Ruas-Madiedo, P; Gómez, E; Solís, G; Fernández, N; Suárez, A; Suárez, M; Salazar, N; de los Reyes-Gavilán; CG and Gueimonde, M. Real-Time monitoring of HT29 epithelial cells as an in vitro model for assessing functional differences among intestinal microbiotas from different population groups. Journal of Microbiological Methods. 2018. 152:210-216.
Gutiérrez-Díaz, I; Fernández-Navarro, T; Salazar, N; Bartolomé, B; Moreno-Arribas, MV; López, P; Suárez, A; de los Reyes-Gavilán, CG; Gueimonde, M and González, S. Could fecal phenylacetic and phenylpropionic acids be used as indicators of health status? Journal of Agricultural and Food Chemistry. 2018. 66(40):10438-10446.
Gómez-Gallego, C; Gueimonde, M; Salminen, S. The role of yogurt in food-based dietary guidelines. Nutrition Reviews . 2018. 76(Supplement_1):29-39
Moris, G; Arboleya, S; Mancabeli, L; Mlani, C, Ventura, M; de los Reyes-Gavilán, CG and Gueimonde, M. Fecal microbiota profile in a group of myasthenia gravis patients. Scientific Reports. 2018. 8(1):14384.
Díaz, M; Guadamuro, L; Espinosa-Martos, I; Mancabelli, L; Jiménez, S; Molinos-Norniella, C; Pérez-Solís, D; Milani, C; Rodríguez, JM; Ventura, M; Bousoño, C; Gueimonde, M; Margolles, A; Díaz, JJ and Delgado, S. Microbiota and derived parameters in fecal samples of non-IgE cow`s milk protein allergy infants under restriction diet. Nutrients. 2018. 10(10): E1481.
